AdvanSix Inc.
Financials
Valuation Metrics
AdvanSix Inc.'s Market Cap is $438M. At end of 2025 it was $466M. Ranked #2834 of 3,121 in US market (top 91%), #1585 of 1,658 on NYSE (top 96%), #165 of 173 in Materials (top 95%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $438M | US#2,834/3,121 Sec#165/173 |
| Revenue | $1.56B | US#1,599/3,121 Sec#109/173 |
| Net Income | $-18M | US—/3,121 Sec—/173 |
| Total Assets | $1.67B | US#2,197/3,121 Sec#124/173 |
| Net Assets | $797M | US#1,925/3,121 Sec#118/173 |
| Employees | 1,410 | US#1,857/3,121 Sec#113/173 |
| Value | ||
| P/B | 0.55x | US#90/3,121 Sec#4/173 |
| P/S | 0.28x | US#147/3,121 Sec#9/173 |
| EV/EBITDA | 16.30x | US#1,690/3,121 Sec#112/173 |
| FCF Yield | -5.89% | US—/3,121 Sec—/173 |
| Profitability | ||
| ROE | -2.22% | US#2,199/3,121 Sec#124/173 |
| ROA | -1.06% | US#2,314/3,121 Sec#126/173 |
| Op. Margin | -1.42% | US#2,398/3,121 Sec#133/173 |
| Revenue Growth | 2.96% | US#2,001/3,121 Sec#110/173 |
| Earnings Growth | -122.92% | US#1,915/3,121 Sec#103/173 |
| Financial Health | ||
| Debt Ratio | 109.94% | US#1,189/3,121 Sec#105/173 |
| Total Debt | $424M | US#1,955/3,121 Sec#111/173 |
| FCF | $-26M | US#2,453/3,121 Sec#133/173 |
| Cash | $7M | US#3,007/3,121 Sec#170/173 |
| Current Ratio | 1.28x | US#1,905/3,121 Sec#152/173 |
| Net Debt/EBITDA | 7.95x | US#2,295/3,121 Sec#138/173 |
| Dividend | ||
| Div. Yield | 3.94% | US#456/3,121 Sec#17/173 |
| Div. Growth | 0.24% | US#1,223/3,121 Sec#76/173 |
| Performance | ||
| 1Y Return | -23.01% | US#2,394/3,121 Sec#151/173 |
| 1M Return | -4.81% | US#789/3,121 Sec#71/173 |
| From 52W High | -39.28% | US#2,380/3,121 Sec#132/173 |
| 1Y MDD | -39.55% | US#1,997/3,121 Sec#101/173 |
| Trading | ||
| Volume | 203,894 shares | US#2,701/3,121 Sec#144/173 |
| Trading Value | $3M | US#2,816/3,121 Sec#161/173 |
| Per Share | ||
| EPS | $-0.66 | US—/3,121 Sec—/173 |
| BPS | $29.56 | US#898/3,121 Sec#56/173 |
Company Info
AdvanSix Inc. operates as a global manufacturer and supplier of polymer resins, serving markets across the United States and internationally. A key offering is Nylon 6, a versatile synthetic polymer resin utilized in the production of fibers, filaments, specialized plastics, and films. The company's portfolio also includes caprolactam, an essential building block for other polymer resins, and ammonium sulfate fertilizers, which it distributes to farm cooperatives, retailers, and other channel partners. Furthermore, AdvanSix supplies acetone, a crucial ingredient for manufacturing adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins. Its extensive range additionally comprises various intermediate chemicals, such as phenol, alpha-methyl styrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. These offerings are marketed under established brands like Aegis, Capra, Sulf-N, Nadone, Naxol, and EZ-Blox. AdvanSix utilizes a dual sales approach, engaging directly with customers while also leveraging a network of distributors. The company, established in 2016, is headquartered in Parsippany, New Jersey.